Gary Earl Duncan, Ph.D. - Publications

Affiliations: 
University of North Carolina - Chapel Hill University of North Carolina, Chapel Hill, Chapel Hill, NC 

97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Duncan GE, Koller BH, Moy SS. Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function. Brain Research. 1443: 98-105. PMID 22297176 DOI: 10.1016/j.brainres.2012.01.009  0.96
2010 Duncan GE, Inada K, Koller BH, Moy SS. Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function. Brain Research. 1307: 166-76. PMID 19840778 DOI: 10.1016/j.brainres.2009.10.023  0.96
2009 Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS. Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Research. 1265: 186-95. PMID 19232330 DOI: 10.1016/j.brainres.2009.02.002  0.96
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews. 60: 358-403. PMID 18922967 DOI: 10.1124/pr.107.00107  0.96
2008 Duncan GE, Inada K, Farrington JS, Koller BH. Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction. Brain Research. 1221: 41-8. PMID 18550035 DOI: 10.1016/j.brainres.2008.05.001  0.96
2008 Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behavioural Brain Research. 188: 178-94. PMID 18068825 DOI: 10.1016/j.bbr.2007.10.029  0.96
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection (Pharmacological Reviews (2002) 60, (358-403)) Pharmacological Reviews. 60: 582.  0.96
2007 Inada K, Farrington JS, Moy SS, Koller BH, Duncan GE. Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 899-908. PMID 17318306 DOI: 10.1007/s00702-007-0628-5  0.96
2006 Duncan GE, Moy SS, Lieberman JA, Koller BH. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacology, Biochemistry, and Behavior. 85: 481-91. PMID 17097724 DOI: 10.1016/j.pbb.2006.09.017  0.96
2006 Marx CE, Shampine LJ, Duncan GE, VanDoren MJ, Grobin AC, Massing MW, Madison RD, Bradford DW, Butterfield MI, Lieberman JA, Morrow AL. Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy? Pharmacology, Biochemistry, and Behavior. 84: 598-608. PMID 16962649 DOI: 10.1016/j.pbb.2006.07.026  0.96
2006 Moy SS, Perez A, Koller BH, Duncan GE. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Research. 1089: 186-94. PMID 16638606 DOI: 10.1016/j.brainres.2006.03.073  0.96
2006 Duncan GE, Moy SS, Lieberman JA, Koller BH. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology. 184: 190-200. PMID 16362405 DOI: 10.1007/s00213-005-0214-1  0.96
2005 Duncan GE, Kohn H. The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model. Epilepsy Research. 67: 81-7. PMID 16214306 DOI: 10.1016/j.eplepsyres.2005.08.009  0.96
2005 Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular Psychiatry. 10: 79-104. PMID 15289815 DOI: 10.1038/sj.mp.4001556  0.96
2004 Miyamoto S, Snouwaert JN, Koller BH, Moy SS, Lieberman JA, Duncan GE. Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2180-8. PMID 15467708 DOI: 10.1038/sj.npp.1300548  0.96
2004 Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behavioural Brain Research. 153: 507-19. PMID 15265649 DOI: 10.1016/j.bbr.2004.01.008  0.96
2003 Miyamoto S, LaMantia AS, Duncan GE, Sullivan P, Gilmore JH, Lieberman JA. Recent advances in the neurobiology of schizophrenia. Molecular Interventions. 3: 27-39. PMID 14993436 DOI: 10.1124/mi.3.1.27  0.96
2003 Duncan GE, Miyamoto S, Lieberman JA. Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation. The Journal of Pharmacology and Experimental Therapeutics. 305: 999-1005. PMID 12626664 DOI: 10.1124/jpet.102.048140  0.96
2003 Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1-13. PMID 12496935 DOI: 10.1038/sj.npp.1300015  0.96
2002 Duncan G, Miyamoto S, Gu H, Lieberman J, Koller B, Snouwaert J. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function. Brain Research. 951: 166-76. PMID 12270494 DOI: 10.1016/S0006-8993(02)03156-6  0.96
2001 Knapp DJ, Braun CJ, Duncan GE, Qian Y, Fernandes A, Crews FT, Breese GR. Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration. Alcoholism, Clinical and Experimental Research. 25: 1662-72. PMID 11707641  0.96
2001 Miyamoto S, Mailman RB, Lieberman JA, Duncan GE. Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors. Brain Research. 894: 167-80. PMID 11251190 DOI: 10.1016/S0006-8993(01)01991-6  0.96
2000 Moy SS, Knapp DJ, Duncan GE, Breese GR. Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil. Psychopharmacology. 152: 208-15. PMID 11057525 DOI: 10.1007/s002130000507  0.96
2000 Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biological Psychiatry. 47: 1000-4. PMID 10838068 DOI: 10.1016/S0006-3223(99)00305-4  0.96
2000 Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. The Journal of Pharmacology and Experimental Therapeutics. 293: 8-14. PMID 10734147  0.96
2000 Miyamoto S, Leipzig JN, Lieberman JA, Duncan GE. Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 400-12. PMID 10700659 DOI: 10.1016/S0893-133X(99)00127-X  0.96
2000 Miyamoto S, Duncan GE, Mailman RB, Lieberman JA. Developing novel antipsychotic drugs: Strategies and goals Current Opinion in Central and Peripheral Nervous System Investigational Drugs. 2: 25-39.  0.96
1999 Yui K, Goto K, Ikemoto S, Ishiguro T, Angrist B, Duncan GE, Sheitman BB, Lieberman JA, Bracha SH, Ali SF. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Molecular Psychiatry. 4: 512-23. PMID 10578232  0.96
1999 Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Research. 843: 171-83. PMID 10528123 DOI: 10.1016/S0006-8993(99)01776-X  0.96
1999 Duncan GE, Zorn S, Lieberman JA. Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia. Molecular Psychiatry. 4: 418-28. PMID 10523814  0.96
1999 Duncan GE, Sheitman BB, Lieberman JA. An integrated view of pathophysiological models of schizophrenia. Brain Research. Brain Research Reviews. 29: 250-64. PMID 10209235 DOI: 10.1016/S0165-0173(99)00002-8  0.96
1998 Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry. 44: 1099-117. PMID 9836014 DOI: 10.1016/S0006-3223(98)00187-5  0.96
1998 Duncan GE, Leipzig JN, Mailman RB, Lieberman JA. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Research. 812: 65-75. PMID 9813244 DOI: 10.1016/S0006-8993(98)00926-3  0.96
1998 Moy SS, Duncan GE, Knapp DJ, Breese GR. Sensitivity to ethanol across development in rats: comparison to [3H]zolpidem binding. Alcoholism, Clinical and Experimental Research. 22: 1485-92. PMID 9802533  0.96
1998 Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Pharmacology, Biochemistry, and Behavior. 60: 439-48. PMID 9632227 DOI: 10.1016/S0091-3057(98)00018-5  0.96
1998 Knapp DJ, Duncan GE, Crews FT, Breese GR. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcoholism, Clinical and Experimental Research. 22: 481-93. PMID 9581657  0.96
1998 Duncan GE, Knapp DJ, Carson SW, Breese GR. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. The Journal of Pharmacology and Experimental Therapeutics. 285: 579-87. PMID 9580601  0.96
1998 Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Research. 787: 181-90. PMID 9518601 DOI: 10.1016/S0006-8993(97)01390-5  0.96
1996 Duncan GE, Knapp DJ, Breese GR. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Research. 713: 79-91. PMID 8724978 DOI: 10.1016/0006-8993(95)01486-1  0.96
1996 Little KY, Kirkman JA, Duncan GE. Beta-adrenergic receptor subtypes in human pineal gland. Journal of Pineal Research. 20: 15-20. PMID 8648557  0.96
1996 Duncan GE, Knapp DJ, Johnson KB, Breese GR. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. The Journal of Pharmacology and Experimental Therapeutics. 277: 1076-89. PMID 8627519  0.96
1995 McCown TJ, Duncan GE, Johnson KB, Breese GR. Metabolic and functional mapping of the neural network subserving inferior collicular seizure generalization. Brain Research. 701: 117-28. PMID 8925273 DOI: 10.1016/0006-8993(95)00970-X  0.96
1995 Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL, Morrow AL. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience. 64: 1113-28. PMID 7753379 DOI: 10.1016/0306-4522(94)00433-6  0.96
1995 Criswell HE, Simson PE, Knapp DJ, Devaud LL, McCown TJ, Duncan GE, Morrow AL, Breese GR. Effect of zolpidem on gamma-aminobutyric acid (GABA)-induced inhibition predicts the interaction of ethanol with GABA on individual neurons in several rat brain regions. The Journal of Pharmacology and Experimental Therapeutics. 273: 526-36. PMID 7714808  0.96
1995 Devaud LL, Morrow AL, Criswell HE, Breese GR, Duncan GE. Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain. Alcoholism, Clinical and Experimental Research. 19: 910-4. PMID 7485838 DOI: 10.1111/j.1530-0277.1995.tb00966.x  0.96
1994 Breese GR, Criswell HE, Johnson KB, O'Callaghan JP, Duncan GE, Jensen KF, Simson PE, Mueller RA. Neonatal destruction of dopaminergic neurons. Neurotoxicology. 15: 149-59. PMID 8090354  0.96
1994 Duncan GE, Henson OW. Brain activity patterns in flying, echolocating bats (Pteronotus parnellii): assessment by high resolution autoradiographic imaging with [3H]2-deoxyglucose. Neuroscience. 59: 1051-70. PMID 8058119 DOI: 10.1016/0306-4522(94)90305-0  0.96
1994 Duncan GE, Knapp DJ, Little KY, Breese GR. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 271: 1699-704. PMID 7996487  0.96
1994 Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62: 65-85. PMID 7816213 DOI: 10.1016/0306-4522(94)90315-8  0.96
1993 Duncan GE, Breese GR, Criswell HE, Johnson KB, Schambra UB, Mueller RA, Caron MG, Fremeau RT. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development. Journal of Neurochemistry. 61: 1255-62. PMID 8376983  0.96
1993 Duncan GE, Johnson KB, Breese GR. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 3932-43. PMID 8366353  0.96
1993 Little KY, Kirkman JA, Ivy Carroll F, Clark TB, Duncan GE. Cocaine use increases [3H]WIN 35428 binding sites in human striatum Brain Research. 628: 17-25. PMID 8313144 DOI: 10.1016/0006-8993(93)90932-D  0.96
1993 Little KY, Clark TB, Ranc J, Duncan GE. β-adrenergic receptor binding in frontal cortex from suicide victims Biological Psychiatry. 34: 596-605. PMID 8292688 DOI: 10.1016/0006-3223(93)90151-3  0.96
1993 Little KY, Kirkman JA, Carroll FI, Breese GR, Duncan GE. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. Journal of Neurochemistry. 61: 1996-2006. PMID 8245956  0.96
1993 Criswell HE, Simson PE, Duncan GE, McCown TJ, Herbert JS, Morrow AL, Breese GR. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels. The Journal of Pharmacology and Experimental Therapeutics. 267: 522-37. PMID 8229784  0.96
1993 Duncan GE, Paul IA, Breese GR. Neuroanatomical differences in the rate of beta-adrenergic receptor adaptation after repeated treatment with imipramine. Psychopharmacology Bulletin. 29: 401-7. PMID 8121968  0.96
1993 Breese GR, Morrow AL, Simson PE, Criswell HE, McCown TJ, Duncan GE, Keir WJ. The neuroanatomical specificity of ethanol action on ligand-gated ion channels: a hypothesis. Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement. 2: 309-13. PMID 7538301  0.96
1992 Simson PE, Johnson KB, Jurevics HA, Criswell HE, Napier TC, Duncan GE, Mueller RA, Breese GR. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat. The Journal of Pharmacology and Experimental Therapeutics. 263: 1454-63. PMID 1361576  0.96
1992 Duncan GE, Little KY, Kirkman JA, Kaldas RS, Stumpf WE, Breese GR. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns. Brain Research. 591: 181-97. PMID 1332802 DOI: 10.1016/0006-8993(92)91699-F  0.96
1992 Little KY, Duncan GE, Breese GR, Stumpf WE. Beta-adrenergic receptor binding in human and rat hypothalamus. Biological Psychiatry. 32: 512-22. PMID 1332783 DOI: 10.1016/0006-3223(92)90219-P  0.96
1991 Duncan GE, Paul IA, Fassberg JB, Powell KR, Stumpf WE, Breese GR. Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: comparison to in vitro binding patterns. Pharmacology, Biochemistry, and Behavior. 38: 621-31. PMID 2068199 DOI: 10.1016/0091-3057(91)90024-V  0.96
1991 Fremeau RT, Duncan GE, Fornaretto MG, Dearry A, Gingrich JA, Breese GR, Caron MG. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 88: 3772-6. PMID 2023928  0.96
1991 McCown TJ, Duncan GE, Breese GR. Neuroanatomical characterization of inferior collicular seizure genesis: 2-deoxyglucose and stimulation mapping. Brain Research. 567: 25-32. PMID 1815827 DOI: 10.1016/0006-8993(91)91431-Y  0.96
1991 Duncan GE, Stumpf WE. Brain activity patterns: Assessment by high resolution autoradiographic imaging of radiolabeled 2-deoxyglucose and glucose uptake Progress in Neurobiology. 37: 365-382. PMID 1758965 DOI: 10.1016/0301-0082(91)90023-T  0.96
1991 Paul IA, Duncan GE, Mueller RA, Hong JS, Breese GR. Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms. European Journal of Pharmacology. 205: 135-43. PMID 1687466 DOI: 10.1016/0014-2999(91)90811-4  0.96
1991 Duncan GE, Little KY, Koplas PA, Kirkman JA, Breese GR, Stumpf WE. Beta-adrenergic receptor distribution in human and rat hippocampal formation: marked species differences. Brain Research. 561: 84-92. PMID 1665753 DOI: 10.1016/0006-8993(91)90752-H  0.96
1990 Duncan GE, Kaldas RG, Mitra KE, Breese GR, Stumpf WE. High activity neurons in the reticular formation of the medulla oblongata: a high-resolution autoradiographic 2-deoxyglucose study. Neuroscience. 35: 593-600. PMID 2381517 DOI: 10.1016/0306-4522(90)90331-W  0.96
1990 Paul IA, Duncan GE, Kuhn C, Mueller RA, Hong JS, Breese GR. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. The Journal of Pharmacology and Experimental Therapeutics. 252: 997-1005. PMID 2157002  0.96
1990 Breese GR, Criswell HE, Duncan GE, Mueller RA. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat. Brain Research Bulletin. 25: 477-84. PMID 2127238 DOI: 10.1016/0361-9230(90)90240-Z  0.96
1989 Stumpf WE, Heiss C, Sar M, Duncan GE, Craver C. Dexamethasone and corticosterone receptor sites - Differential topographic distribution in rat hippocampus revealed by high resolution autoradiography Histochemistry. 92: 201-210. PMID 2777639 DOI: 10.1007/BF00500919  0.96
1989 Duncan GE, Stumpf WE, Breese GR, Mitra KE. Functional activity patterns in the forebrain of swimming rats: a 5 min 2-deoxyglucose study. Neuroscience Letters. 100: 111-6. PMID 2761758 DOI: 10.1016/0304-3940(89)90669-1  0.96
1989 Duncan GE, Oglesby SA, Greenwood RS, Meeker RB, Hayward JN, Stumpf WE. Metabolic mapping of functional activity in rat brain and pituitary after water deprivation. Neuroendocrinology. 49: 489-95. PMID 2725842 DOI: 10.1159/000125157  0.96
1989 Breese GR, Criswell HE, Duncan GE, Mueller RA. Dopamine deficiency in self-injurious behavior. Psychopharmacology Bulletin. 25: 353-7. PMID 2697009  0.96
1989 Duncan GE, Brüstle O, Heiss C, Breese GR, Stumpf WE. Topographical assessment of accumulated radioactivity from [14C]2-deoxyglucose and [6(-14C)]glucose in rat forebrain at different survival periods. Neuroscience. 32: 813-22. PMID 2601848 DOI: 10.1016/0306-4522(89)90301-1  0.96
1989 Duncan GE, Paul IA, Powell KR, Fassberg JB, Stumpf WE, Breese GR. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites. The Journal of Pharmacology and Experimental Therapeutics. 248: 470-7. PMID 2536433  0.96
1988 Duncan GE, Stumpf WE, Brüstle O, Givens BS, Breese GR, Pilgrim C. Topography of basal glucose utilization in the hippocampus determined with [1-14C]glucose and [6-14C]glucose. Neuroscience. 24: 877-83. PMID 3380305 DOI: 10.1016/0306-4522(88)90074-7  0.96
1988 Brüstle O, Duncan GE, Hu W, Pilgrim C, Breese GR, Stumpf WE. Topography of basal glucose utilization in rat thalamus and hypothalamus determined with (1-14C)-glucose. Anatomy and Embryology. 179: 1-17. PMID 3213951 DOI: 10.1007/BF00305095  0.96
1988 Paul IA, Duncan GE, Powell KR, Mueller RA, Hong JS, Breese GR. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. The Journal of Pharmacology and Experimental Therapeutics. 246: 956-62. PMID 2843636  0.96
1988 Pertsch M, Duncan GE, Stumpf WE, Pilgrim C. A histochemical study of the regional distribution in the rat brain of enzymatic activity hydrolyzing glucose- and 2-deoxyglucose-6-phosphate Histochemistry. 88: 257-262. PMID 2835334 DOI: 10.1007/BF00570281  0.96
1987 Duncan GE, Stumpf WE, Pilgrim C. Cerebral metabolic mapping at the cellular level with dry-mount autoradiography of [3H]2-deoxyglucose Brain Research. 401: 43-49. PMID 3815093 DOI: 10.1016/0006-8993(87)91161-9  0.96
1987 Duncan GE, Stumpf WE, Pilgrim C, Breese GR. High resolution autoradiography at the regional topographic level with [14C]2-deoxyglucose and [3H]2-deoxyglucose. Journal of Neuroscience Methods. 20: 105-13. PMID 3600030 DOI: 10.1016/0165-0270(87)90043-4  0.96
1987 Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. The Journal of Pharmacology and Experimental Therapeutics. 243: 1027-34. PMID 3121842  0.96
1987 Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. The Journal of Pharmacology and Experimental Therapeutics. 240: 167-76. PMID 3100767  0.96
1986 Duncan GE, Pilgrim C, Stumpf WE, McCown TJ, Breese GR, Mueller RA. High resolution autoradiographic determination of the topographic distribution of radioactivity in the hippocampal formation after injection of [1-14C]glucose or 2-deoxy[14C]glucose. Neuroscience. 17: 99-106. PMID 3960318 DOI: 10.1016/0306-4522(86)90228-9  0.96
1986 Duncan GE, Breese GR, Criswell H, Stumpf WE, Mueller RA, Covey JB. Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. The Journal of Pharmacology and Experimental Therapeutics. 238: 758-62. PMID 3016250  0.96
1986 Breese GR, Mueller RA, Napier TC, Duncan GE. Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease. Advances in Experimental Medicine and Biology. 204: 197-215. PMID 2947429  0.96
1985 Parvizi N, Sar M, Duncan GE, Stumpf WE. Autoradiographic determination of catechol estrogen binding sites in brain, pituitary and uterus Brain Research. 344: 373-376. PMID 4041885 DOI: 10.1016/0006-8993(85)90818-2  0.96
1985 de Castro JM, Duncan G. Operantly conditioned running: Effects on brain catecholamine concentrations and receptor densities in the rat Pharmacology, Biochemistry and Behavior. 23: 495-500. PMID 2999830 DOI: 10.1016/0091-3057(85)90407-1  0.96
1985 Duncan GE, Paul IA, Harden TK, Mueller RA, Stumpf WE, Breese GR. Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. The Journal of Pharmacology and Experimental Therapeutics. 234: 402-8. PMID 2991500  0.96
1985 Duncan GE, Stumpf WE. A combined autoradiographic and immunocytochemical study of 3H-corticosterone target neurons and catecholamine neurons in rat and mouse lower brain stem Neuroendocrinology. 40: 262-271. PMID 2859539  0.96
1985 Paul IA, Duncan G, Breese GR, Mueller RA. Rapid elevation of TRH-like immunoreactivity (TRH-LI) by combined electroconvulsive shock (ECS) and imipramine (IMI) Federation Proceedings. 44: No. 2779.  0.96
1984 Duncan GE, Stumpf WE. Target neurons for [3H]corticosterone in the rat spinal cord Brain Research. 307: 321-326. PMID 6467001 DOI: 10.1016/0006-8993(84)90486-4  0.96
1984 Duncan GE, Paul I, Mueller RA. Rapid down regulation of β-adrenergic receptors by the combination of swim stress and imipramine Federation Proceedings. 43: no. 3834.  0.96
1981 Rowell PP, Duncan GE. The subsynaptosomal distribution and release of [3H]acetylcholine synthesized by rat cerebral cortical synaptosomes Neurochemical Research. 6: 1265-1282. PMID 7339505 DOI: 10.1007/BF00964348  0.96
1980 Bannon MJ, Jarboe CH, Carr LA, Duncan GE. Central nervous system actions of 2,5-bis(3,4-dimethoxybenzyl) cyclopentyl amine, a peripheral dopamine blocking agent. Life Sciences. 26: 225-29. PMID 7360005 DOI: 10.1016/0024-3205(80)90297-0  0.96
1979 Duncan GE, Dagirmanjian R. Δ9-Tetrahydrocannabinol Sensitization of the rat brain to direct cholinergic stimulation Psychopharmacology. 60: 237-240. PMID 108700 DOI: 10.1007/BF00426661  0.96
1978 Duncan GE, Dagirmanjian R. 9Δ-Tetrahydrocannabinol sensitization of the rat brain to direct cholinergic stimulation Federation Proceedings. 37: No. 341.  0.96
Show low-probability matches.